Zoraida Moreno Weidmann

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 311 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Prospective validation of a 1-hour algorithm to rule-out and rule-in acute myocardial infarction using a high-sensitivity cardiac troponin T assay

Tobias Reichlin, Raphael Twerenbold, Karin Wildi et al. · Canadian Medical Association Journal · 2015 · 227 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Optimal Cutoff Levels of More Sensitive Cardiac Troponin Assays for the Early Diagnosis of Myocardial Infarction in Patients With Renal Dysfunction

Raphael Twerenbold, Karin Wildi, Cédric Jaeger et al. · Circulation · 2015 · 210 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Misdiagnosis of Myocardial Infarction Related to Limitations of the Current Regulatory Approach to Define Clinical Decision Values for Cardiac Troponin

Karin Wildi, María Rubini Giménez, Raphael Twerenbold et al. · Circulation · 2015 · 137 citations · Full text

Medicine, Cardiology, Internal Medicine +17

One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I

Cédric Jaeger, Karin Wildi, Raphael Twerenbold et al. · American Heart Journal · 2015 · 114 citations

Medicine, Cardiology, Internal Medicine +13